DaltonTx is building the intelligence backbone for drug discovery — combining AI, human expertise and experimental data into one continuous learning engine.
The Dalton platform spans small molecules and biologics. It captures what worked, what failed and why, with full context, so judgement compounds over time. Agents propose strategies, weigh trade-offs and orchestrate AI, physics and ML tools autonomously. The result: smarter decisions, fewer wasted experiments and the confidence to tackle harder biology.
Founded on University of Oxford research and built by leaders behind AI discovery platforms at AstraZeneca and Exscientia, DaltonTx pairs state-of-the-art scientific AI with secure, enterprise-grade engineering.